Showing results (201-210 of 321) with videos related to

Sort By:
Pageof 33
Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1987
Peritoneal accumulation of infused stroma-free hemoglobin. Potential toxicity of an oxygen-carrying substituteT S Velky, E S Lee, P W Maffuid, et al.
The Journal of Urology|June 24, 1999
Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in placeJ R Wagner, M M Walther, W M Linehan, et al.
Scandinavian Journal of Gastroenterology|December 29, 1998
Vacuolating toxin gene polymorphism among Helicobacter pylori clinical isolates and its association with m1, m2, or chimeric vacA middle typesJ C Yang, C H Kuo, H J Wang, et al.
The American Journal of Gastroenterology|August 1, 1997
Genetic analysis of the cytotoxin-associated gene and the vacuolating toxin gene in Helicobacter pylori strains isolated from Taiwanese patientsJ C Yang, T H Wang, H J Wang, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 20, 2001
A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapyJ C Yang, K C Yang, C T Hsu, et al.
The Journal of Urology|July 4, 2001
Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinomaJ R Vasselli, J C Yang, W M Linehan, et al.
Gastroenterology|June 26, 1999
Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomachC S Chang, L T Chen, J C Yang, et al.
Acta Anaesthesiologica Sinica|September 1, 1994
Cancer pain management: a recent experience by anaesthesiologists in a teaching hospital in Hong KongS L Tsui, W N Tong, C S Lam, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 1993
Primary soft tissue sarcomas of the breast: local-regional control with post-operative radiotherapyP A Johnstone, L J Pierce, M J Merino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphomaJ S Weber, J C Yang, S L Topalian, et al.
Pageof 33